Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

DNA
Ginkgo Bioworks Holdings, Inc.
stock NYSE

At Close
Aug 29, 2025 3:59:53 PM EDT
12.67USD+4.108%(+0.50)2,039,508
0.00Bid   0.00Ask   0.00Spread
Pre-market
Aug 29, 2025 9:14:30 AM EDT
12.08USD-0.703%(-0.09)2,100
After-hours
Aug 29, 2025 4:45:30 PM EDT
12.51USD-1.263%(-0.16)1,542
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 28, 2022
11:20AM EST  Why BofA Sees 'Better Entry Point' In Ginkgo Bioworks Stock   Benzinga
10:17AM EST  Benzinga's Top Ratings Upgrades, Downgrades For January 28, 2022   Benzinga
08:56AM EST  B of A Securities Initiates Coverage On Ginkgo Bioworks Holdings with Buy Rating, Announces Price Target of $8   Benzinga
Jan 26, 2022
12:39PM EST  Ginkgo Bioworks Holdings Option Alert: Feb 18 $6 Calls Sweep (59) near the Ask: 3474 @ $0.4 vs 3380 OI; Earnings 2/25 Before Open [est] Ref=$5.185   Benzinga
Jan 19, 2022
11:57AM EST  Ginkgo Bioworks Holdings Option Alert: Feb 18 $6 Puts at the Bid: 3000 @ $1.3 vs 524 OI; Earnings 2/25 Before Open [est] Ref=$5.01   Benzinga
07:04AM EST  Ginkgo Bioworks Announces Acquisition Of Massachusetts COVID-19 Testing Provider Project Beacon COVID-19 LLC; Terms Not Disclosed   Benzinga
07:02AM EST  Ginkgo Bioworks Announces Acquisition of Massachusetts COVID-19 Testing   PR Newswire
Jan 18, 2022
04:32PM EST  Pomerantz LLP is investigating claims on behalf of investors of Ginkgo Bioworks Holdings, Inc. (Ginkgo or the Company) (NYSE:DNA). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.   GlobeNewswire Inc
Jan 17, 2022
08:13AM EST  Final Deadline Reminder: Kessler Topaz Meltzer & Check, LLP   GlobeNewswire Inc
Jan 13, 2022
03:04PM EST  2022 Deadline in Securities Fraud Class Action Lawsuit Filed Against of Ginkgo Bioworks Holdings, Inc. Investors   PR Newswire
01:10PM EST  Pomerantz LLP is investigating claims on behalf of investors of Ginkgo Bioworks Holdings, Inc. (Ginkgo or the Company) (NYSE:DNA). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.   GlobeNewswire Inc
Jan 12, 2022
12:10PM EST  Ginkgo Bioworks shares were trading higher after the company reported preliminary unaudited 2021 revenue highlights and business review.   Benzinga
07:05AM EST  Ginkgo Bioworks Says Prelim. Unaudited Foundry Revenue Expected To Exceed $100M For FY21, Biosecurity Revenue Expected To Exceed $110M   Benzinga
07:03AM EST  Ginkgo Bioworks Expects To Meet Or Exceed 2021 Performance Targets For New Cell Programs   RTTNews
07:01AM EST  Ginkgo Bioworks Provides Preliminary Unaudited 2021 Revenue Highlights and   PR Newswire
Jan 11, 2022
10:06AM EST  Z, OWLT & DNA Bronstein, Gewirtz & Grossman,   GlobeNewswire Inc
Jan 10, 2022
08:57AM EST  Final Deadline Approaching on January 18, 2022: Kessler Topaz   GlobeNewswire Inc
08:14AM EST  Inscripta Reports Ginkgo Bioworks Adopted Co.'s Onyx Genome Engineering Platform   Benzinga
07:44AM EST  Selecta Biosciences And Ginkgo Bioworks Announce New Collaboration To Develop Next-Generation Gene Therapy Capsids   Benzinga
07:01AM EST  Selecta Biosciences and Ginkgo Bioworks Announce New Collaboration to Develop   PR Newswire
07:00AM EST  Selecta Biosciences and Ginkgo Bioworks Announce New Collaboration   GlobeNewswire Inc
Jan 7, 2022
01:07PM EST  Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022   Benzinga
01:01PM EST  BTIG Initiates Coverage On Ginkgo Bioworks Holdings with Buy Rating, Announces Price Target of $12   Benzinga
Jan 6, 2022
07:14AM EST  Optimvia And Ginkgo Bioworks Announce Partnership To Manufacture Biosynthetic Heparin   Benzinga
07:03AM EST  Optimvia And Ginkgo Bioworks Partner To Manufacture Biosynthetic Heparin   RTTNews
07:01AM EST  Optimvia and Ginkgo Bioworks Announce Partnership to Manufacture Biosynthetic   PR Newswire
Jan 5, 2022
11:11AM EST  Bioworks Holdings, Inc. Shareholders of Securities Fraud Class Action Lawsuit   PR Newswire
11:07AM EST  Stocks That Hit 52-Week Lows On Wednesday   Benzinga
07:01AM EST  Ginkgo Bioworks Announces Participation in 40th Annual J.P. Morgan Healthcare   PR Newswire
Jan 4, 2022
04:14PM EST  Pomerantz LLP is investigating claims on behalf of investors of Ginkgo Bioworks Holdings, Inc. (Ginkgo or the Company) (NYSE:DNA). Such investors are advised to contact Robert S. Willoughby atnewaction@pomlaw.com or 888-476-6529, ext. 7980.   GlobeNewswire Inc
Jan 2, 2022
09:18PM EST  DNA Reminder: Kessler Topaz Meltzer & Check, LLP - January 18,   GlobeNewswire Inc
Dec 28, 2021
08:44PM EST  Investor Alert: Kessler Topaz Meltzer & Check, LLP Reminds Ginkgo Bioworks   PR Newswire
Dec 27, 2021
03:40PM EST  Pomerantz LLP is investigating claims on behalf of investors of Ginkgo Bioworks Holdings, Inc. (Ginkgo or the Company) (NYSE:DNA). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.   GlobeNewswire Inc
Dec 25, 2021
04:38PM EST  DNA DEADLINE REMINDER: Kessler Topaz Meltzer & Check, LLP   GlobeNewswire Inc
Dec 20, 2021
12:14PM EST  Gingko, XpresSpa Saturday Reported Concentric, XpresCheck Confirmed First North American Detections Of Novel BA.3 Sublineage Of Omicron Variant Through CDC COVID-19 Air Travel Biosecurity Program   Benzinga
07:09AM EST  Benjamin Franklin Institute Of Tech, Ginkgo Bioworks To Launch Biotechnology Manufacturing Associates Degree   RTTNews
07:01AM EST  Benjamin Franklin Institute of Technology, Ginkgo Bioworks to Launch   PR Newswire
Dec 19, 2021
08:48PM EST  Holdings, Inc. Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm   PR Newswire
08:44PM EST  Pomerantz LLP is investigating claims on behalf of investors of Ginkgo Bioworks Holdings, Inc. (Ginkgo or the Company) (NYSE:DNA). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.   GlobeNewswire Inc
Dec 18, 2021
12:34AM EST  of Novel BA.3 Sublineage of Omicron Variant through CDC COVID-19 Air Travel Biosecurity Program   PR Newswire
Dec 17, 2021
08:43AM EST  SHAREHOLDER ALERT: Kessler Topaz Meltzer & Check, LLP Reminds DNA   GlobeNewswire Inc
Dec 11, 2021
07:18PM EST  DNA Deadline Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of   PR Newswire
Dec 9, 2021
05:56PM EST  Investor Deadline Alert: Kessler Topaz Meltzer & Check, LLP   GlobeNewswire Inc
Dec 7, 2021
06:51PM EST  Pomerantz LLP is investigating claims on behalf of investors of Ginkgo Bioworks Holdings, Inc. (Ginkgo or the Company) (NYSE:DNA). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.   GlobeNewswire Inc
07:09AM EST  Concentric By Ginkgo Confirms Detection Of Omicron Variant Through COVID-19 Air Travel Biosecurity Collaboration   RTTNews
07:08AM EST  Ginkgo Bioworks Says Has Collected, Identified And Sequenced Pooled Sample Containing Omicron Variant From South Africa And UK-Originated Passengers   Benzinga
07:01AM EST  Concentric by Ginkgo Confirms Detection of Omicron Variant through COVID-19 Air   PR Newswire
Dec 4, 2021
12:02PM EST  LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors With   PR Newswire
Nov 30, 2021
06:59PM EST  Pomerantz LLP is investigating claims on behalf of investors of Ginkgo Bioworks Holdings, Inc. (Ginkgo or the Company) (NYSE:DNA). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.   GlobeNewswire Inc
06:32PM EST  Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder   GlobeNewswire Inc
04:49PM EST  XpresSpa Group, Ginkgo Bioworks Says Collaboration With CDC COVID-19 Biosurveillance Program Expands To Include Detection Of Omicron Variant   Benzinga
09:00AM EST  XpresSpa Group, Inc. (Nasdaq: XSPA) (XpresSpa or the Company), a health and wellness company, today announced through a joint effort with the Centers for Disease Control and Prevention (CDC) and Ginkgo Bioworks (NYSE: DNA), the expansion of its current COVID-19 variant surveillance program to detect the new Omicron variant through its XpresCheck subsidiary.   GlobeNewswire Inc
Nov 24, 2021
05:32PM EST  Levi & Korsinsky, LLP, Researching Possible Securities Law Violations - Ginkgo   PR Newswire
10:16AM EST  Gainey McKenna & Egleston announces that a class action lawsuit has been filed against of Ginkgo Bioworks Holdings, Inc. (Ginkgo or the Company) (NYSE: DNA) in the United States District Court for the Northern District of California on behalf of those who purchased Ginkgo common stock between May 11, 2021 and October 5, 2021, inclusive (the Class Period).   GlobeNewswire Inc
07:01AM EST  Ginkgo Bioworks Announces Participation in Upcoming Conferences   PR Newswire
Nov 23, 2021
05:48PM EST  Bioworks Holdings, Inc. f/k/a Soaring Eagle Acquisition Corp. Shareholders of Securities Fraud Class Action Lawsuit   PR Newswire
Nov 22, 2021
03:27PM EST  Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud   GlobeNewswire Inc
12:31PM EST  Pomerantz LLP is investigating claims on behalf of investors of Ginkgo Bioworks Holdings, Inc. (Ginkgo or the Company) (NYSE:DNA). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.   GlobeNewswire Inc
Nov 20, 2021
09:30AM EST  LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors With   PR Newswire
Nov 19, 2021
07:11PM EST  Pomerantz LLP is investigating claims on behalf of investors of Ginkgo Bioworks Holdings, Inc. (Ginkgo or the Company) (NYSE:DNA). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.   GlobeNewswire Inc
Nov 17, 2021
07:04AM EST  mRNA Victoria and Ginkgo Bioworks Announce Partnership to Grow the Bioeconomy & International Biosecurity Capabilities   Benzinga
07:01AM EST  mRNA Victoria and Ginkgo Bioworks Announce Partnership to Grow the Bioeconomy &   PR Newswire
Nov 15, 2021
11:07AM EST  Earnings Scheduled For November 15, 2021   Benzinga
10:59AM EST  Ginkgo Bioworks Says Received Informal Inquiry From DOJ Following Oct. Short Report   Benzinga
10:58AM EST  Ginkgo Bioworks Holdings Q3 EPS $(0.08) Misses $(0.03) Estimate, Sales $77.61M Beat $45.75M Estimate   Benzinga
07:58AM EST  Ginkgo Bioworks Holdings, Inc. (DNA) reported on Monday that third-quarter net loss attributable to the company sharply widened to $101.88 million or $0.08 per share from $26.06 million or $0.02 per share in the prior-year quarter.   RTTNews
07:36AM EST  Ginkgo Bioworks Q3 Total Revenue Rises To $77.6 Mln From $13.3 Mln Prior Year   RTTNews
07:32AM EST  Ginkgo Bioworks Reports Third Quarter 2021 Results   PR Newswire
Nov 11, 2021
07:05AM EST  Ginkgo Bioworks Launches Cell Development Kit Service For Standardized, Low-Cost Entry To Its Cell Programming Platform   Benzinga
07:01AM EST  Ginkgo Bioworks Launches Cell Development Kit Service for Standardized,   PR Newswire
Nov 9, 2021
11:31AM EST  Synlogic And Ginkgo Bioworks Announce Nomination Of SYNB1353 Investigational Synthetic Biotic Medicine For Treatment Of Homocystinuria   Benzinga
07:02AM EST  Synlogic and Ginkgo Bioworks Announce Investigational Synthetic Biotic Medicine   PR Newswire
Nov 8, 2021
08:03AM EST  Ginkgo Bioworks Announces Date of Third Quarter 2021 Results Presentation   PR Newswire
Nov 1, 2021
04:51PM EDT  Pomerantz LLP is investigating claims on behalf of investors of Ginkgo Bioworks Holdings, Inc. (Ginkgo or the Company) (NYSE:DNA). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.   GlobeNewswire Inc
Oct 28, 2021
08:03AM EDT  Ginkgo Bioworks Previews Today's Annual Ferment Conference   PR Newswire
Oct 27, 2021
09:03AM EDT  Series A To Build a New Foundation For the Beauty Industry through Expressive Biology   PR Newswire
Oct 26, 2021
08:03AM EDT  Selecta Biosciences and Ginkgo Bioworks Announce Partnership to Advance   PR Newswire
08:01AM EDT  Selecta Biosciences Reports Partnership With Ginkgo Bioworks To Advance Treatments For Orphan, Rare Diseases   Benzinga
08:00AM EDT  Leveraging Ginkgos cell programming platform and Selectas ImmTOR platform to create potentially transformative enzymatic therapies   GlobeNewswire Inc
Oct 20, 2021
08:38AM EDT  Quest Diagnostics To Provide K-12 School COVID-19 Testing In Collaboration With Ginkgo Bioworks   RTTNews
08:38AM EDT  Quest Diagnostics Reports Deal With Texas Dept. Of State Health Services To Provide COVID-19 Kindergarten Through Grade 12 School Testing Services; Ginkgo Bioworks Will Provide Support Services   Benzinga
08:37AM EDT  Ginkgo Bioworks to Support Safer Classroom Learning in Texas for New Statewide School Testing Program   PR Newswire
08:17AM EDT  Ginkgo Bioworks Announces Participation in Jefferies Gene Therapy/Editing Summit Oct. 27   Benzinga
08:01AM EDT  Ginkgo Bioworks Announces Participation in Jefferies Gene Therapy/Editing Summit   PR Newswire
Oct 19, 2021
02:35PM EDT  Mid-Afternoon Market Update: Dow Surges Over 100 Points; Harmony Biosciences Shares Spike Higher   Benzinga
Oct 18, 2021
07:26PM EDT  Hagens Berman urges Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) investors with significant losses to submit your losses now.   GlobeNewswire Inc
Oct 13, 2021
01:38PM EDT  Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2021   Benzinga
01:38PM EDT  Raymond James Initiates Coverage On Ginkgo Bioworks Holdings with Outperform Rating, Announces Price Target of $14.5   Benzinga
Oct 12, 2021
12:53PM EDT  Ginkgo Bioworks Holdings Says CDC Awards Co Contract At San Francisco Airports, JFK And Newark Airports   Benzinga
10:48AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2021   Benzinga
06:42AM EDT  William Blair Initiates Coverage On Ginkgo Bioworks Holdings with Outperform Rating   Benzinga
Oct 11, 2021
05:38PM EDT  The law firm of Kessler Topaz Meltzer & Check, LLP is currently investigating potential violations of the federal securities laws on behalf of shareholders of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) (Ginkgo) f/k/a Soaring Eagle Acquisition Corp. (Nasdaq: SRNG) (Soaring Eagle).   GlobeNewswire Inc
03:52PM EDT  Pomerantz LLP is investigating claims on behalf of investors of Ginkgo Bioworks Holdings, Inc. (Ginkgo or the Company) (NYSE:DNA). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.   GlobeNewswire Inc
09:31AM EDT  Hagens Berman urges Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) investors with significant losses to submit your losses now.   GlobeNewswire Inc
03:48AM EDT  Cathie Wood's Ark Invest Piles Up Another $15.8M In Gingko On Dip Amid Short-Seller Allegations   Benzinga
Oct 8, 2021
04:32PM EDT  Securities Fraud Claims on Behalf of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) Investors   PR Newswire
Oct 7, 2021
09:32AM EDT  to Contact Firm's Attorneys Now, Firm Investigating Possible Securities Law Violations   PR Newswire
Oct 6, 2021
08:15PM EDT  The law firm of Kessler Topaz Meltzer & Check, LLP is currently investigating potential violations of the federal securities laws on behalf of shareholders of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) (Ginkgo) f/k/a Soaring Eagle Acquisition Corp. (Nasdaq: SRNG) (Soaring Eagle).   GlobeNewswire Inc
05:34PM EDT  Hagens Berman urges Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) investors with significant losses to submit your losses now.   GlobeNewswire Inc
04:33PM EDT  EXCLUSIVE: Ginkgo Bioworks CEO Responds To Short Seller Reports, Says Claim Co. Platform Is A Place For New Startups To Secure Capital, Launch Quickly Is Not A Problem   Benzinga
12:19PM EDT  Ginkgo Tumbles 22%, Lowest Since Listing   RTTNews
10:23AM EDT  Mid-Morning Market Update: Markets Open Lower; Acuity Brands Posts Upbeat Q4 Results   Benzinga
Sep 30, 2021
07:01AM EDT  Ginkgo Bioworks Announces Participation in Upcoming Conferences   PR Newswire
Sep 27, 2021
02:43AM EDT  Cathie Wood Buys Another $6.5M In Robinhood, $6.3M In Peloton   Benzinga
Sep 20, 2021
10:04AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2021   Benzinga
06:04AM EDT  HSBC Initiates Coverage On Ginkgo Bioworks Holdings with Buy Rating, Announces Price Target of $14   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC